A&L Goodbody (ALG) is the proud winner of two awards at the Chambers Ireland Sustainable Business Impact Awards 2020, announced yesterday afternoon.
Our Belfast office has announced social enterprise and wellbeing charity Inspire as its new charity partner.
BelfastOur colleague Tomás Murphy has co-written an Inclusion Ireland report on the impact of COVID-19 on people with Intellectual Disabilities.
Our Belfast office has advised local property development firm Oakland Holdings on the redevelopment, letting and refinancing of Merchant Square...
Commercial Property BelfastVincent Power, Partner and Head of EU, Competition & Procurement Group and Liam Kennedy, a Partner in the Litigation & Dispute Resolution Department, have been appointed as senior counsel.
EU, Competition & ProcurementIn a post-coronavirus world, a strong commitment to training and development is vital for any employer that wants to attract quality graduates
On 28 July 2020, John Whelan (Head of Commercial Technology at ALG) spoke alongside privacy activist Max Schrems, at the 'CJEU Privacy Ruling Explained' event, hosted by the European American Chamber of Commerce in New York.
Our Belfast office has partnered with Ulster Business on the publication of its Top 100 Companies report for the fifth consecutive year.
BelfastOur Belfast office has advised Mzuri Holdings Limited – owner of Decora Blind Systems and Domus Lumina, a leading European manufacturer and distributor of indoor window coverings with operations in Northern Ireland, England and Lithuania – on its acquisitions of UK-based Swift Blinds Direct and Netherlands-based Coolblinds.
Corporate and M&A BelfastOur virtual conference brought together leading experts, regulators and law enforcement officials to discuss key issues and new developments in the corporate crime and regulation space.
Regulatory Risk & InvestigationsFor the ninth year in a row, A&L Goodbody has been voted Ireland's 'Most Popular Graduate Recruiter in Law' in the 2020 gradireland Graduate Recruitment Awards.
Our Belfast office has advised global healthtech company Neurovalens on a £5.1m funding round, which will be used to expand on the success of its initial clinical trials and develop its technology’s application for other medical conditions.
